Kyle Busch explains how Richard Childress Racing lost its early Next Gen edge and what the team is changing for the 2026 ...

The latest announcement is out from Illumina ( (ILMN) ).

The DNA Diagnostics Market is poised for growth due to increasing chronic and infectious diseases. Opportunities lie in next-generation sequencing advancements and oncology diagnostics, driven by ...

T cells sit at the center of modern immunotherapy, yet many of the rules that govern their activation, differentiation, dysfunction (e.g., exhaustion), and ...

The use of next-generation sequencing (NGS) technologies to detect B-cell receptor (BCR) or T-cell receptor (TCR) clonotypes ...

ASH 2025 immunotherapy data highlight the importance of treatment sequencing, real-world outcomes in high-risk populations, ...

What started as a bold idea — to make high-quality woodworking education accessible, modern, and industry-driven — has evolved into a proven model that is gaining momentum across the country. The ...

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

Programmatic control, AI integration, and automated workflows for high-frequency design.

BabySeq is a clinical trial exploring how to responsibly share genetic risk information found in the DNA of healthy babies.

Qiagen is a consumable molecular diagnostics and life-science tools platform and offers QuantiFERON, QIAstat-Dx, QIAcuity ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.